204 related articles for article (PubMed ID: 24867009)
1. Genomics-enabled drug repositioning and repurposing: insights from an IOM Roundtable activity.
Power A; Berger AC; Ginsburg GS
JAMA; 2014 May; 311(20):2063-4. PubMed ID: 24867009
[No Abstract] [Full Text] [Related]
2. The economics of genomic medicine: insights from the IOM Roundtable on Translating Genomic-Based Research for Health.
Feero WG; Wicklund C; Veenstra DL
JAMA; 2013 Mar; 309(12):1235-6. PubMed ID: 23532238
[No Abstract] [Full Text] [Related]
3. Envisioning an actionable research agenda to facilitate repurposing of off-patent drugs.
Austin CP; Mount BA; Colvis CM
Nat Rev Drug Discov; 2021 Oct; 20(10):723-724. PubMed ID: 34045734
[No Abstract] [Full Text] [Related]
4. Repurposing Drugs in Oncology: Next Steps.
Verbaanderd C; Meheus L; Huys I; Pantziarka P
Trends Cancer; 2017 Aug; 3(8):543-546. PubMed ID: 28780930
[TBL] [Abstract][Full Text] [Related]
5. NIH proposes new drug development centre.
Bristol N
Lancet; 2011 Feb; 377(9767):705-6. PubMed ID: 21374848
[No Abstract] [Full Text] [Related]
6. Stimulus funds force hard look at comparative effectiveness research.
Tuma RS
J Natl Cancer Inst; 2009 Aug; 101(15):1036-9. PubMed ID: 19638502
[No Abstract] [Full Text] [Related]
7. Conflicts of interest. IOM panel backs public disclosure of drug company payments.
Kaiser J
Science; 2009 May; 324(5927):579. PubMed ID: 19407172
[No Abstract] [Full Text] [Related]
8. Biomarker Tests for Molecularly Targeted Therapies--The Key to Unlocking Precision Medicine.
Lyman GH; Moses HL
N Engl J Med; 2016 Jul; 375(1):4-6. PubMed ID: 27353537
[No Abstract] [Full Text] [Related]
9. Pioneering government-sponsored drug repositioning collaborations: progress and learning.
Frail DE; Brady M; Escott KJ; Holt A; Sanganee HJ; Pangalos MN; Watkins C; Wegner CD
Nat Rev Drug Discov; 2015 Dec; 14(12):833-41. PubMed ID: 26585533
[TBL] [Abstract][Full Text] [Related]
10. Challenges and Opportunities for Genomics Education: Insights from an Institute of Medicine Roundtable Activity.
Dougherty MJ; Wicklund C; Johansen Taber KA
J Contin Educ Health Prof; 2016; 36(1):82-5. PubMed ID: 26954250
[TBL] [Abstract][Full Text] [Related]
11. Can the Institute of Medicine review the FDA?
Carroll BJ
Nat Med; 2005 Apr; 11(4):369. PubMed ID: 15812509
[No Abstract] [Full Text] [Related]
12. Building stem-cell genomics in California and beyond.
Dewitt ND; Yaffe MP; Trounson A
Nat Biotechnol; 2012 Jan; 30(1):20-5. PubMed ID: 22231086
[No Abstract] [Full Text] [Related]
13. Challenges and recommendations for obtaining chemical structures of industry-provided repurposing candidates.
Southan C; Williams AJ; Ekins S
Drug Discov Today; 2013 Jan; 18(1-2):58-70. PubMed ID: 23159359
[TBL] [Abstract][Full Text] [Related]
14. A lifecycle approach to the evaluation of FDA approval methods and regulatory actions: opportunities provided by a new IOM report.
Psaty BM; Meslin EM; Breckenridge A
JAMA; 2012 Jun; 307(23):2491-2. PubMed ID: 22563032
[No Abstract] [Full Text] [Related]
15. Doubters ask if IOM report will foster more sharing of clinical trial data.
Rice S
Mod Healthc; 2015 Jan; 45(3):10. PubMed ID: 25671895
[No Abstract] [Full Text] [Related]
16. Contraceptive technology. Panel wants to break R&D barrier.
Service RF
Science; 1996 May; 272(5266):1258. PubMed ID: 8650534
[No Abstract] [Full Text] [Related]
17. Reply to "Can the Institute of Medicine review the FDA?".
Fineberg HV
Nat Med; 2005 Jun; 11(6):589. PubMed ID: 15937463
[No Abstract] [Full Text] [Related]
18. Next steps in clinical trial redesign.
Nicholas J
J Natl Cancer Inst; 2012 Jan; 104(2):90-2. PubMed ID: 22215851
[No Abstract] [Full Text] [Related]
19. The roles of academia, rare diseases, and repurposing in the development of the most transformative drugs.
Kesselheim AS; Tan YT; Avorn J
Health Aff (Millwood); 2015 Feb; 34(2):286-93. PubMed ID: 25646109
[TBL] [Abstract][Full Text] [Related]
20. IOM outlines framework for postmarket safety.
Reinke T
Manag Care; 2012 Aug; 21(8):10-1. PubMed ID: 22957462
[No Abstract] [Full Text] [Related]
[Next] [New Search]
